A Prospective Cohort Study to Assess Obstructive Respiratory Disease Phenotypes and Endotypes in Japan: The TRAIT Study Design

References

• World Health Organisation. Chronic respiratory diseases; 2020. Available from: https://www.who.int/health-topics/chronic-respiratory-diseases. Accessed June 2, 2021.
   Google Scholar
• Iheanacho I, Zhang S, King D, Rizzo M, Ismaila AS. Economic burden of Chronic Obstructive Pulmonary Disease (COPD): a systematic literature review. Int J Chron Obstruct Pulmon Dis. 2020;15:439–460. doi:10.2147/COPD.S234942
   PubMed Web of Science ®Google Scholar
• Murray CJL, Barber RM, Foreman KJ, et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. Lancet. 2015;386(10009):2145–2191.
   PubMed Web of Science ®Google Scholar
• Forum of International Respiratory Societies. The Global Impact of Respiratory Disease – Second Edition. Sheffield, European Respiratory Society, 2017.
   Google Scholar
• Global Initiative for Asthma. Diagnosis and initial treatment of asthma, COPD and asthma-COPD Overlap; 2017. Available from: https://ginasthma.org/wp-content/uploads/2019/11/GINA-GOLD-2017-overlap-pocket-guide-wms-2017-ACO.pdf. Accessed October 16, 2020.
   Google Scholar
• Yamamura K, Hara J, Kobayashi T, et al. The prevalence and clinical features of asthma-COPD overlap (ACO) definitively diagnosed according to the Japanese Respiratory Society Guidelines for the Management of ACO 2018. j Med Invest. 2019;66(1.2):157–164. doi:10.2152/jmi.66.157
   PubMed Web of Science ®Google Scholar
• Bonten TN, Kasteleyn MJ, de Mutsert R, et al. Defining asthma–COPD overlap syndrome: a population-based study. Eur Respir J. 2017;49(5):1602008. doi:10.1183/13993003.02008-2016
   PubMed Web of Science ®Google Scholar
• Japanese Respiratory Society. The JRS guidelines for the management of ACO; 2018.
   Google Scholar
• Yanagisawa S, Ichinose M. Definition and diagnosis of asthma-COPD overlap (ACO). Allergol Int. 2018;67(2):172–178. doi:10.1016/j.alit.2018.01.002
   PubMed Web of Science ®Google Scholar
• Agusti A. The path to personalised medicine in COPD. Thorax. 2014;69(9):857–864. doi:10.1136/thoraxjnl-2014-205507
   PubMed Web of Science ®Google Scholar
• Bateman ED, Reddel HK, van Zyl-smit RN, Agusti A. The asthma-COPD overlap syndrome: towards a revised taxonomy of chronic airways diseases? Lancet Respir Med. 2015;3(9):719–728. doi:10.1016/S2213-2600(15)00254-4
   PubMed Web of Science ®Google Scholar
• Hizawa N. Clinical approaches towards asthma and chronic obstructive pulmonary disease based on the heterogeneity of disease pathogenesis. Clin Exp Allergy. 2016;46(5):678–687. doi:10.1111/cea.12731
   PubMed Web of Science ®Google Scholar
• Pavord ID, Beasley R, Agusti A, et al. After asthma: redefining airways diseases. Lancet (London, England). 2018;391(10118):350–400.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma. Global strategy for asthma management and prevention; 2020. Available from: https://ginasthma.org/. Accessed September 26, 2020.
   Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of Chronic Obstructive Pulmonary Disease, 2021 report; 2021. Available from: https://goldcopd.org/gold-reports/. Accessed June 2, 2021.
   Google Scholar
• Agusti A, Bel E, Thomas M, et al. Treatable traits: toward precision medicine of chronic airway diseases. Eur Respir J. 2016;47(2):410–419. doi:10.1183/13993003.01359-2015
   PubMed Web of Science ®Google Scholar
• Hizawa N. LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes. Int J Chron Obstruct Pulmon Dis. 2015;10:1093–1102. doi:10.2147/COPD.S72858
   PubMed Web of Science ®Google Scholar
• Couper D, LaVange LM, Han M, et al. Design of the subpopulations and intermediate outcomes in COPD study (SPIROMICS). Thorax. 2014;69(5):491–494. doi:10.1136/thoraxjnl-2013-203897
   PubMed Web of Science ®Google Scholar
• Faner R, Tal-Singer R, Riley JH, et al. Lessons from ECLIPSE: a review of COPD biomarkers. Thorax. 2014;69(7):666–672. doi:10.1136/thoraxjnl-2013-204778
   PubMed Web of Science ®Google Scholar
• Regan EA, Hokanson JE, Murphy JR, et al. Genetic epidemiology of COPD (COPDGene) study design. Copd. 2010;7(1):32–43. doi:10.3109/15412550903499522
   PubMedGoogle Scholar
• Simpson AJ, Hekking -P-P, Shaw DE, et al. Treatable traits in the European U-BIOPRED adult asthma cohorts. Allergy. 2019;74(2):406–411. doi:10.1111/all.13629
   PubMed Web of Science ®Google Scholar
• Vestbo J, Anderson W, Coxson HO, et al. Evaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE). Eur Respir J. 2008;31(4):869–873. doi:10.1183/09031936.00111707
   PubMed Web of Science ®Google Scholar
• ClinialTrials.jp. Obstructive respiratory disease phenotyping and endotyping study (TheTRAIT Study) in Japan; 2019. Available from: https://www.clinicaltrials.jp/cti-user/trial/ShowDirect.jsp?japicId=JapicCTI-194844. Accessed February 18, 2021.
   Google Scholar
• Reddel HK, Gerhardsson de Verdier M, Agustí A, et al, Prospective observational study in patients with obstructive lung disease: NOVELTY design. ERJ Open Res. 2019;5(1):00036–2018. doi:10.1183/23120541.00036-2018
   PubMedGoogle Scholar
• Juniper EF, Svensson K, Mork AC, Stahl E. Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir Med. 2005;99(5):553–558. doi:10.1016/j.rmed.2004.10.008
   PubMed Web of Science ®Google Scholar
• Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George’s Respiratory Questionnaire. Am Rev Respir Dis. 1992;145(6):1321–1327. doi:10.1164/ajrccm/145.6.1321
   PubMed Web of Science ®Google Scholar
• Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest. 1988;93(3):580–586. doi:10.1378/chest.93.3.580
   PubMed Web of Science ®Google Scholar
• Rennard SI. The promise of observational studies (ECLIPSE, SPIROMICS, and COPDGene) in achieving the goal of personalized treatment of Chronic Obstructive Pulmonary Disease. Semin Respir Crit Care Med. 2015;36(4):478–490. doi:10.1055/s-0035-1555609
   PubMed Web of Science ®Google Scholar
• Barnes N, Ishii T, Hizawa N, et al. The distribution of blood eosinophil levels in a Japanese COPD clinical trial database and in the rest of the world. Int J Chron Obstruct Pulmon Dis. 2018;13:433–440. doi:10.2147/COPD.S144108
   PubMed Web of Science ®Google Scholar
• Vestbo J, Reddel HK, Agustí A, et al. Characteristics by physician-assigned severity of asthma, asthma+COPD and COPD patients in the NOVELTY study. Eur Respir J. 2019;54(suppl 63):PA5029.
   Google Scholar
• Rennard SI, Locantore N, Delafont B, et al. Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysis. Ann Am Thorac Soc. 2015;12(3):303–312. doi:10.1513/AnnalsATS.201403-125OC
   PubMed Web of Science ®Google Scholar
• Suzuki M, Makita H, Ito YM, Nagai K, Konno S, Nishimura M. Clinical features and determinants of COPD exacerbation in the Hokkaido COPD cohort study. Eur Respir J. 2014;43(5):1289–1297. doi:10.1183/09031936.00110213
   PubMed Web of Science ®Google Scholar
• Takiguchi H, Takeuchi T, Niimi K, et al. Proportion and clinical characteristics of non-asthmatic non-smokers among adults with airflow obstruction. PLoS One. 2018;13(5):e0196132. doi:10.1371/journal.pone.0196132
   PubMed Web of Science ®Google Scholar
• ClinialTrials.gov. A prospective cohort study of asthma and COPD overlap in Japanese COPD patients using the diagnostic criteria of The Japanese Respiratory Society (ACO-Registry). Available from: https://clinicaltrials.gov/ct2/show/NCT03577795. Accessed June 2, 2021.
   Google Scholar
• Cosío BG, Dacal D. Pérez de Llano L. Asthma-COPD overlap: identification and optimal treatment. Ther Adv Respir Dis. 2018;12:1753466618805662. doi:10.1177/1753466618805662
   Web of Science ®Google Scholar
• McDonald VM, Hiles SA, Godbout K, et al. Treatable traits can be identified in a severe asthma registry and predict future exacerbations. Respirology (Carlton, Vic). 2019;24(1):37–47. doi:10.1111/resp.13389
   PubMed Web of Science ®Google Scholar
• McDonald VM, Clark VL, Cordova-Rivera L, Wark PAB, Baines KJ, Gibson PG. Targeting treatable traits in severe asthma: a randomised controlled trial. Eur Respir J. 2020;55(3). doi:10.1183/13993003.01509-2019
   Web of Science ®Google Scholar
• Pascoe S, Barnes N, Brusselle G, et al. Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial. Lancet Respir Med. 2019;7(9):745–756. doi:10.1016/S2213-2600(19)30190-0
   PubMed Web of Science ®Google Scholar
• Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648–654. doi:10.1183/09031936.00102509
   PubMed Web of Science ®Google Scholar
• Gupta N, Pinto LM, Morogan A, Bourbeau J. The COPD assessment test: a systematic review. Eur Respir J. 2014;44(4):873–884. doi:10.1183/09031936.00025214
   PubMed Web of Science ®Google Scholar